Jd

John de Koning

Partner at EQT Life Sciences (formerly LSP)

Amsterdam, North Holland

VC
Investor

Invests in

  • Min Investment:

    $11,000,000.00

  • Max Investment:

    $65,000,000.00

  • Target Investment:

    $25,000,000.00

Skills

Lifesciences
R&D
Biotechnology
Oncology
Molecular Biology
Immunology
Commercialization
Biopharmaceuticals
Technology Transfer
Biochemistry
Drug Discovery
Drug Development
Genomics
Clinical Trials
Genetics
Cell Culture
Hardware Diagnostics
Clinical Development
Cancer
Cell Biology

Education

Lists including John

AM
Al
AF
AV

Based in Amsterdam

273 people

AT
AS
AT
AH

All Series A Investors

14752 people

Investments

Tubulis

Series B

Total Funding: $210M

VarmX

Series B

Total Funding: $83M

etherna immunotherapies

Series A

Total Funding: $66M

Visus Therapeutics

Debt Financing

Total Funding: $61M

Onward

Series Unknown

Total Funding: $51M

Merus

Series B

Total Funding: $150M

Work Experience

EL
EQT Life Sciences

2022

  • Partner

    2022

    EQT Life Sciences (formerly LSP), is one of Europe’s largest and most experienced healthcare investment firms, targeting innovative life sciences and health care companies.

VT
Visus Therapeutics, Inc.

2021

  • Board Member

    2021

x
xilis

2021

  • Board Observer

    2021

V
VarmX

2020

  • Board Member

    2020

XT
XyloCor Therapeutics, Inc.

2018

  • Board Observer

    2018

eI
eTheRNA Immunotherapies

2016

  • Board Member

    2016

O
ONWARD

2016

  • Board Member

    2016

Aelin Therapeutics

2017 - 2023

  • Board Member

    2017 - 2023

L(
LSP (Life Sciences Partners)

2006 - 2022

  • General Partner

    2006 - 2022

    LSP acquired by EQT and rebranded into EQT Life Sciences

M
Merus

2010 - 2020

  • Board Member

    2010 - 2020